Bill > HB4834

Introduced Session

Amends the Illinois Controlled Substances Act. Provides that the Prescription Monitoring Program does not apply to testosterone, mifepristone, misoprostol, GnRH analogues, or estrogen. Provides that the Department of Human Services shall purge from the records of the Prescription Monitoring Program all existing information concerning the prescribing or dispensing of testosterone, including any such information contained in the central repository or database, on or before January 1, 2027, and shall ensure that no further records concerning the prescribing and dispensing of testosterone are created or maintained by the Prescription Monitoring Program. Provides that the Department shall update and adopt rules consistent with the provision no later than January 1, 2027. Effective immediately.

AI Summary

Committee Categories

Kelly Cassidy (D)*,  Adriane Johnson (D)*,  Jaime Andrade (D),  Dee Avelar (D),  Amy Briel (D),  Javier Cervantes (D),  Sharon Chung (D),  Justin Cochran (D),  Michael Crawford (D),  Dan Didech (D),  Mary Edly-Allen (D),  Laura Ellman (D),  Sara Feigenholtz (D),  Laura Fine (D),  Graciela Guzmán (D),  Maura Hirschauer (D),  Mattie Hunter (D),  Emil Jones (D),  Dave Koehler (D),  Lindsey LaPointe (D),  Kimberly Lightford (D),  Theresa Mah (D),  Joyce Mason (D),  Anna Moeller (D),  Kevin Olickal (D),  Robert Peters (D),  Mike Simmons (D),  Elgie Sims (D),  Rachel Ventura (D),  Karina Villa (D),  Celina Villanueva (D),  Ram Villivalam (D),  Mark Walker (D),  Chris Welch (D), 

Sent to the Governor (on 06/11/2026)

Bill Topics

Official Document